- Home
- Companies
- MedChemExpress LLC (MCE)
- Products
- MedChemExpress - Model MitoBloCK-6 - ...
MedChemExpress - Model MitoBloCK-6 - 303215-67-0
MitoBloCK-6 is a potent Erv1/ALR inhibitor, with an IC50 of 900 nM and 700 nM, respectively. MitoBloCK-6 also inhibits Erv2 (IC50=1.4 μM). MitoBloCK-6 can induce apoptosis via cytochrome c release in hESCs[1].MCE products for research use only. We do not sell to patients.
MitoBloCK-6
MCE China:MitoBloCK-6
Brand:MedChemExpress (MCE)
Cat. No.HY-122652
CAS:303215-67-0
Purity:98.07%
Storage:4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Shipping:Room temperature in continental US; may vary elsewhere.
Description:MitoBloCK-6 is a potent Erv1/ALR inhibitor, with an IC50 of 900 nM and 700 nM, respectively. MitoBloCK-6 also inhibits Erv2 (IC50=1.4 μM). MitoBloCK-6 can induce Apoptosis via cytochrome c release. MitoBloCK-6 inhibits growth of developing zebrafish motor neurons. MitoBloCK-6 has anticancer activity against liver cancer and leukemia.
In Vitro:MitoBloCK-6 (20 μM, 8 h) induces apoptosis via cytochrome c release in human embryonic stem cells (hESCs)[1]. MitoBloCK-6 (20-40 μM, 72 h) inhibits proliferation of liver cancer cells McA-RH7777 via mitochondrial impairment[2]. MitoBloCK-6 kills leukemia cell lines (OCI-AML2, TEX, Jurkat and NB4) with an IC50 of 5-10 µM[3]. MitoBloCK-6 (0.078-5 μM) increases the differentiation of OCI-AML2 and NB4 cells via inhibition of ALR, as increased surface expression of the myeloid markers CD11b[4]. MitoBloCK-6 results in a significant decrease in the growth and branching of developing zebrafish motor neurons via inhibition of ALR[5].
In Vivo:MitoBloCK-6 (80 mg/kg, i.p., 5 of 7 days, twice daily) reduces tumor growth and the engraftment of AML cells into the marrow in mice xenografted with OCI-AML2 cells[4]. MitoBloCK-6 (80 mg/kg i.p. 5 of 7 days, 2 weeks) strongly reduces the engraftment of primary AML cells in mice[6].
IC50 & Target:IC50: 900 nM (Erv1) 700 nM (ALR) 1.4 μM (Erv2)[1] In Vitro MitoBloCK-6 (20 μM, 8 h) induces apoptosis via cytochrome c release in human embryonic stem cells (hESCs)[1]. MitoBloCK-6 (20-40 μM, 72 h) inhibits proliferation of liver cancer cells McA-RH7777 via mitochondrial impairment[2]. MitoBloCK-6 kills leukemia cell lines (OCI-AML2, TEX, Jurkat and NB4) with an IC50 of 5-10 µM[3]. MitoBloCK-6 (0.078-5 μM) increases the differentiation of OCI-AML2 and NB4 cells via inhibition of ALR, as increased surface expression of the myeloid markers CD11b[4]. MitoBloCK-6 results in a significant decrease in the growth and branching of developing zebrafish motor neurons via inhibition of ALR[5]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> MitoBloCK-6 Related Antibodies Apoptosis Analysis [1] Cell Line: human embryonic stem cells
Hot selling product:mTRP-2 (180-188) | Diminazene (aceturate) | ReAsH-EDT2 | Agomelatine | Tebipenem | alpha-Cyperone | IFN-alpha 2/IFNA2, Mouse (His) | Aldosterone-d7 | Alofanib | Lipoic acid
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
References:
[1]. Dabir DV, et, al. A small molecule inhibitor of redox-regulated protein translocation into mitochondria. Dev Cell. 2013 Apr 15;25(1):81-92. [Content Brief]
[2]. Kabiri Y, et al. Mitochondrial Impairment by MitoBloCK-6 Inhibits Liver Cancer Cell Proliferation. Front Cell Dev Biol. 2021 Sep 20;9:725474. [Content Brief]
[4]. Singh RP, et al. Disrupting Mitochondrial Copper Distribution Inhibits Leukemic Stem Cell Self-Renewal. Cell Stem Cell. 2020 Jun 4;26(6):926-937.e10. [Content Brief]
Brand introduction:
• MCE (MedChemExpress) has a global exclusive compound library of more than 200 kinds, and we are committed to providing the most comprehensive range of high-quality small molecule active compounds for scientific research customers around the world;
• More than 50,000 highly selective inhibitors and agonists are involved in various popular signaling pathways and disease areas;
• The products cover a variety of recombinant proteins, peptides, commonly used kits, more PROTAC, ADC and other characteristic products, widely used in new drug research and development, life science and other scientific research projects;
• Provide virtual screening, ion channel screening, metabolomics analysis detection analysis, drug screening and other professional technical services;
• It has a professional experimental center and strict quality control and verification system;
• Provide LC/MS, NMR, HPLC, chiral analysis, elemental analysis and other quality inspection reports to ensure the high purity and high quality of products;
• The biological activity of the products has been verified by the experiments of customers in various countries;
• A variety of top journals such as Nature, Cell, Science and pharmaceutical patents have included the scientific research results of MCE customers;
• Our professional team tracks the latest pharmaceutical and life science research and provides you with the latest active compounds in the world;
• It has established long-term cooperation with the world's major pharmaceutical companies and well-known scientific research institutions。